Categories
Connect with us on LinkedIn
eCOA/ePRO factsheet
Download our ePRO/eCOA factsheet to view an overview of our services.
Strategies to Minimize Participant and Healthcare Provider Burden in Clinical Trials
This article examines strategies to reduce participant and provider burden in clinical trials while ensuring high-quality data collection....
What do we measure with PROs in head and neck cancer? Pain, QoL, adverse events and more
Patient-Reported Outcomes (PROs) are essential in head and neck cancer research, offering insights into symptoms, quality of life,...
2024: Castor Year in Review
As we close the year, the Castor team shares vital milestones the company has achieved to make patient-centric...
Unlocking FDA’s Vision for PRO Collection in RWE: Timing, Methods, and Insights
Discover FDA's guidance on collecting PROs for Real-World Evidence (RWE), focusing on timing, methods, and improving data quality.
FDA’s Vision on PRO/eCOA Collection for RWE: Timing and Methods Explained
Watch back as our panel of experts discuss how the FDA views the collection of patient-reported outcomes for...
Castor Launches “Castor for Impact Program” to Advance Health Equity in Clinical Research
Innovative Program Offers Discounted or Free Access to Clinical Trial Technology, Empowering Underserved Research Areas and Early-Stage Biotech...
DTx company leverages Castor’s Real-World Evidence platform in Registry study
How Castor’s eClinical system helped a DTx company to collect Real World Evidence for their behavioral disorder treatment
Castor Product Spotlight: What’s new in 2024?
In this on-demand webinar, we delve into the latest product updates on eCOA, data entry, reports, and dashboards....
eCOA: Afterthought or Essential Strategy? An Expert’s View on Choosing and Developing an eCOA Strategy
The Evolving Landscape of eCOA in Clinical Trials Clinical trials have long grappled with the complexities of data...
Evaluating “Bother” as a Component of Patient-Reported Outcomes in Clinical Studies
Patient-reported outcome (PRO) instruments refer to multiple scales and questionnaires designed to collect patients’ personal feedback on their...
New Industry Standard Research Report Sheds Light on eCOA/ePRO Market Dynamics
The latest report from Industry Standard Research (ISR) Sheds Light on eCOA/ePRO Market Dynamics. The Performance of Castor...
Revolutionizing Blood Pressure Monitoring: Insights from Aktiia and Castor’s Collaboration
How Aktiia brought their continuous BP device to market by integrating vast amounts of blood pressure data with...
Under Pressure: How Aktiia Brought Their Continuous BP Device to Global Markets with high quality data
Watch this on-demand LinkedIn Live webinar with Castor CEO & founder, Derk Arts, featuring fellow data-driven pioneer, Jay...
5 Best Practices for Getting Started with ePRO
Electronic Patient Reported Outcomes (ePRO) can become a powerhouse for gathering high-quality data directly from patients. To help...
Can BYOD help us end an era of waste and burden in eCOA?
Bring Your Own Device (BYOD) represents the future of eCOA, and prioritizes flexibility & convenience for trial participants....
Spring updates & a highlight on ePRO in Oncology
Listen in as Derk gives an update on what is happening at Castor this March, as well as...
Measuring the true patient experience in Cancer Trials with eCOA / ePRO
Shedding light on the complexities and advancements in measuring PROs, drug tolerability, and quality of life in cancer...